Diabetes PubMed

Insulin pump therapy using a simple dosing regimen significantly improved glycemic control in patients with type 2 diabetes.

Although European groups have initiated innovative clinical research in the field of insulin pump therapy, insulin pump use remains currently limited in many European countries, and well behind that in the United States.

Successful implementation of insulin pump therapy for older patients requires an experienced diabetes management team that can assess patient needs and tailor therapy in the context of age-related disabilities.

Metabolic and psychosocial outcomes did not differ significantly between adolescents using pump therapy and adolescents using multiple daily injections (MDI).

The future direction of insulin pump development is targeted toward closing the loop, to allow feedback control between an insulin pump and a glucose sensor, and hence finer adjustment of insulin delivery rates as required.

The study suggests that insulin pumps compare well with multi-injections with respect to safety and disease control and that most children and adolescents prefer the pumps.

CGM-enabled insulin pump therapy improves glycemia more than conventional pump therapy during the first 6 months of pump use in patients who wear CGM sensors at least 70% of the time.

Although the technical reliability of the insulin pump was generally accepted by all patients regardless of current treatment, clinical disadvantages relating to the use of the pump but more commonly social/psychological factors were named, which resulted in patients being reluctant to try this therapy or discontinuing use of it.